Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3939679
Max Phase: Preclinical
Molecular Formula: C49H59ClN8O9S
Molecular Weight: 971.58
Molecule Type: Small molecule
Associated Items:
ID: ALA3939679
Max Phase: Preclinical
Molecular Formula: C49H59ClN8O9S
Molecular Weight: 971.58
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COCCOCCN1CCO[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cccc4[nH]cnc34)cc2[N+](=O)[O-])C1
Standard InChI: InChI=1S/C49H59ClN8O9S/c1-49(2)16-15-35(41(29-49)34-7-9-36(50)10-8-34)31-55-17-19-57(20-18-55)37-11-13-40(46(27-37)67-45-6-4-5-43-47(45)53-33-52-43)48(59)54-68(62,63)39-12-14-42(44(28-39)58(60)61)51-30-38-32-56(22-24-66-38)21-23-65-26-25-64-3/h4-14,27-28,33,38,51H,15-26,29-32H2,1-3H3,(H,52,53)(H,54,59)/t38-/m1/s1
Standard InChI Key: MQIAIAINUVPTIA-KXQOOQHDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 971.58 | Molecular Weight (Monoisotopic): 970.3814 | AlogP: 7.60 | #Rotatable Bonds: 19 |
Polar Surface Area: 193.73 | Molecular Species: ACID | HBA: 14 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 17 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.15 | CX Basic pKa: 7.95 | CX LogP: 6.10 | CX LogD: 6.23 |
Aromatic Rings: 5 | Heavy Atoms: 68 | QED Weighted: 0.04 | Np Likeness Score: -1.16 |
1. (2015) Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases, |
Source(1):